2024 Q1 Form 10-K Financial Statement

#000121390024028732 Filed on April 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $7.490M $6.836M $6.836M
YoY Change 187.78% -49.9% -49.9%
Cost Of Revenue $4.837M $3.401M $3.401M
YoY Change 360.19% -37.15% -37.15%
Gross Profit $2.653M $3.435M $3.435M
YoY Change 70.98% -58.28% -58.28%
Gross Profit Margin 35.42% 50.25% 50.25%
Selling, General & Admin $2.669M $7.971M $7.971M
YoY Change 13.89% -44.64% -44.64%
% of Gross Profit 100.6% 232.06% 232.06%
Research & Development $2.336M $2.336M
YoY Change -50.21% -50.21%
% of Gross Profit 67.99% 67.99%
Depreciation & Amortization $3.247M $147.4K $918.9K
YoY Change 926.55% -91.53% -88.27%
% of Gross Profit 122.39% 4.29% 26.75%
Operating Expenses $9.050M $10.33M $10.33M
YoY Change 160.01% -58.18% -83.77%
Operating Profit -$1.560M -$6.899M -$6.899M
YoY Change -19.13% -58.13% -87.56%
Interest Expense $326.0K -$1.130M -$1.130M
YoY Change -166.9% -69.24% 32.4%
% of Operating Profit
Other Income/Expense, Net -$10.18M -$573.3K -$1.704M
YoY Change 1484.39% 159.29% -56.27%
Pretax Income -$11.74M -$8.603M -$8.603M
YoY Change 356.64% -85.5% -85.5%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$11.74M -$11.58M -$11.58M
YoY Change 374.58% -85.53% -85.35%
Net Earnings / Revenue -156.8% -169.36% -169.36%
Basic Earnings Per Share -$0.36 -$31.21
Diluted Earnings Per Share -$0.40 -$31.20 -$31.21
COMMON SHARES
Basic Shares Outstanding 38.80M shares 10.25M shares 371.0K shares
Diluted Shares Outstanding 32.44M shares 371.0K shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.924M $1.171M $768.5K
YoY Change 118.23% 33.46% -12.45%
Cash & Equivalents $1.737M $768.5K
Short-Term Investments $187.0K $403.0K
Other Short-Term Assets $908.0K $49.76K
YoY Change -92.9% -99.61%
Inventory
Prepaid Expenses $98.00K $581.0K
Receivables $290.0K $147.9K $147.9K
Other Receivables $370.3K $370.3K
Total Short-Term Assets $7.095M $1.336M $1.336M
YoY Change 161.66% -91.03% -91.03%
LONG-TERM ASSETS
Property, Plant & Equipment $10.17M $21.69K $21.69K
YoY Change 25039.08% -55.63% -55.63%
Goodwill
YoY Change
Intangibles $100.0K $100.0K
YoY Change -95.38%
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change
Total Long-Term Assets $10.69M $21.69K $21.69K
YoY Change 149.42% -99.53% -99.53%
TOTAL ASSETS
Total Short-Term Assets $7.095M $1.336M $1.336M
Total Long-Term Assets $10.69M $21.69K $21.69K
Total Assets $17.78M $1.358M $1.358M
YoY Change 154.17% -93.02% -93.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.120M $2.165M $2.165M
YoY Change 190.77% 43.37% 43.37%
Accrued Expenses $2.030M $1.415M $2.407M
YoY Change 67.73% -28.02% 22.45%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $23.04M $5.149M $5.149M
YoY Change 234.64% -60.99% -60.99%
Total Short-Term Liabilities $30.19M $10.37M $10.37M
YoY Change 169.4% -54.37% -54.37%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change -100.0%
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $30.19M $10.37M $10.37M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $30.19M $10.37M $10.37M
YoY Change 136.18% -57.32% -57.32%
SHAREHOLDERS EQUITY
Retained Earnings -$58.18M -$179.1M
YoY Change -65.78% 6.91%
Common Stock $45.77M $164.6M
YoY Change -71.7% 2.73%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$12.41M -$9.011M -$9.011M
YoY Change
Total Liabilities & Shareholders Equity $17.78M $1.358M $1.358M
YoY Change 154.17% -93.02% -93.02%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$11.74M -$11.58M -$11.58M
YoY Change 374.58% -85.53% -85.35%
Depreciation, Depletion And Amortization $3.247M $147.4K $918.9K
YoY Change 926.55% -91.53% -88.27%
Cash From Operating Activities -$983.0K -$682.0K -$5.888M
YoY Change -61.26% 51.61% -45.98%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $637.4K $1.237M
YoY Change -100.0% 12647.2% 205.52%
Cash From Investing Activities $637.4K $1.237M
YoY Change -162.44% -131.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.805M 650.0K -$2.767M
YoY Change -136.71% 360.57% -132.05%
NET CHANGE
Cash From Operating Activities -$983.0K -682.0K -$5.888M
Cash From Investing Activities 637.4K $1.237M
Cash From Financing Activities $1.805M 650.0K -$2.767M
Net Change In Cash $822.0K 605.4K -$7.415M
YoY Change -112.09% -145.54% 18.46%
FREE CASH FLOW
Cash From Operating Activities -$983.0K -$682.0K -$5.888M
Capital Expenditures
Free Cash Flow -$983.0K
YoY Change -61.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
371020 shares
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-39096
CY2023 dei Entity Registrant Name
EntityRegistrantName
GRYPHON DIGITAL MINING, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-2242651
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
5953 Mabel Road
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Unit 138
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89110
CY2023 dei City Area Code
CityAreaCode
(877)
CY2023 dei Local Phone Number
LocalPhoneNumber
646-3374
CY2023 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2023 dei Trading Symbol
TradingSymbol
GRYP
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
4100000 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38800340 shares
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023 dei Auditor Name
AuditorName
Marcum llp
CY2023 dei Auditor Location
AuditorLocation
Los Angeles, CA
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
768461 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
877844 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
7000000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
147855 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
429949 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
420082 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1121763 usd
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
1328784 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1336398 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
10758340 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21689 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48880 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
8661272 usd
CY2023Q4 us-gaap Assets
Assets
1358087 usd
CY2022Q4 us-gaap Assets
Assets
19468492 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4820630 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4023183 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
2283806 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
399652 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
568771 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5149000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
13200000 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
2432374 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10369282 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22508134 usd
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
161803 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1407000 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
217083 usd
CY2023Q4 us-gaap Liabilities
Liabilities
10369282 usd
CY2022Q4 us-gaap Liabilities
Liabilities
24294020 usd
CY2023Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
517605 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
517605 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
230140 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
230140 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
52 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
23 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
164583630 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
160207804 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
227000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
347100 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-179144015 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-167565846 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-9011195 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4825528 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1358087 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19468492 usd
CY2023 us-gaap Revenues
Revenues
6836444 usd
CY2022 us-gaap Revenues
Revenues
10458170 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
3401441 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
4911503 usd
CY2023 us-gaap Gross Profit
GrossProfit
3435003 usd
CY2022 us-gaap Gross Profit
GrossProfit
5546667 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2335609 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4088294 usd
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2293767 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5572721 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5677485 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8018255 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
27191 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4421995 usd
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
26528630 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
10334052 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
48629895 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-6899049 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-43083228 usd
CY2023 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1130343 usd
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-853566 usd
CY2023 gryp Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
-370457 usd
CY2022 gryp Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
-2884273 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-63178 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-202820 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-221101 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1703620 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3895762 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8602669 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-46978990 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-701119 usd
CY2023 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-8602669 usd
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-46277871 usd
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-2975500 usd
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-32779739 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-11578169 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-79057610 usd
CY2022 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
955500 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11578169 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-80013110 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
371020 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146393 shares
CY2023 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-23.19
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-322.65
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-8.02
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-223.92
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-31.21
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-546.56
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-11578169 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-79057610 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-72100 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
40577 usd
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-48000 usd
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
245000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11698269 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-78772033 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
59949683 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3925500 usd
CY2022 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-9926 usd
CY2022 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
940000 usd
CY2022 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
9178961 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
843693 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1854565 usd
CY2022 us-gaap Dividends Preferred Stock
DividendsPreferredStock
955500 usd
CY2022 gryp Stock Issued During Period Value Settlement Of Liabilities
StockIssuedDuringPeriodValueSettlementOfLiabilities
49529 usd
CY2022 gryp Stock Issued During Period Value Restricted Stock Vesting
StockIssuedDuringPeriodValueRestrictedStockVesting
50000 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
40577 usd
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
245000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-79057610 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4825528 usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3187101 usd
CY2023 gryp Stock Issued During Period Value Common Shares Issued In A Private Placement Offering
StockIssuedDuringPeriodValueCommonSharesIssuedInAPrivatePlacementOffering
500000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
403501 usd
CY2023 gryp Stock Issued During Period Settlement Of Convertible Notes For Series C Preferred Stock
StockIssuedDuringPeriodSettlementOfConvertibleNotesForSeriesCPreferredStock
3422000 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-72100 usd
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-48000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-11578169 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-9011195 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-11578169 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-79057610 usd
CY2023 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
212601 usd
CY2022 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
221101 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
56855 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
371364 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
403501 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
873929 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
918898 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7834712 usd
CY2023 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
39285 usd
CY2022 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
337350 usd
CY2022 us-gaap Other Noncash Expense
OtherNoncashExpense
597276 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
22506 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
14553 usd
CY2023 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
3065365 usd
CY2022 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
61778605 usd
CY2023 gryp Gains Losses On Convertible Notes
GainsLossesOnConvertibleNotes
-370457 usd
CY2022 gryp Gains Losses On Convertible Notes
GainsLossesOnConvertibleNotes
-2884273 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-63178 usd
CY2022 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
4016194 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8295 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-197647 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-602216 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-257555 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-9700 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
870152 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-324166 usd
CY2022 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
675291 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-410100 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2113249 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5888352 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10900729 usd
CY2022 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
4345260 usd
CY2022 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
31884 usd
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-400000 usd
CY2023 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
1237362 usd
CY2022 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
5000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1237362 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3972144 usd
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
49 usd
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9926 usd
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
9178960 usd
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
1 usd
CY2023 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
500000 usd
CY2022 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
1854565 usd
CY2023 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
1650000 usd
CY2023 gryp Principal Paymentsof Convertible Notes
PrincipalPaymentsofConvertibleNotes
4917356 usd
CY2022 gryp Principal Paymentsof Convertible Notes
PrincipalPaymentsofConvertibleNotes
1432273 usd
CY2022 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
4294500 usd
CY2022 us-gaap Payments For Repurchase Of Redeemable Convertible Preferred Stock
PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock
5250000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2767405 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8635827 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3601 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-22225 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7414794 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6259271 usd
CY2022Q4 gryp Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Continuing Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsContinuingOperations
7877844 usd
CY2021Q4 gryp Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Continuing Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsContinuingOperations
12937554 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
305411 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1504972 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8183255 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14442526 usd
CY2023Q4 gryp Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Continuing Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsContinuingOperations
768461 usd
CY2022Q4 gryp Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Continuing Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsContinuingOperations
7877844 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
305411 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
768461 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8183255 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
15684 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
787187 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
256440 usd
CY2022 gryp Vesting Of Restricted Stock Units
VestingOfRestrictedStockUnits
50000 usd
CY2023 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
3187101 usd
CY2022 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
3925500 usd
CY2023 gryp Settlement Of Convertible Notes In Preferred Stock
SettlementOfConvertibleNotesInPreferredStock
3422000 usd
CY2022 gryp Stock Based Compensation Capitalized As Software Development
StockBasedCompensationCapitalizedAsSoftwareDevelopment
19764 usd
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
17974 usd
CY2023 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
285253 usd
CY2022 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
180647 usd
CY2022 gryp Settlement Of Liabilities With Common Stock
SettlementOfLiabilitiesWithCommonStock
49529 usd
CY2022 gryp Shares Returned In Connection With Acquisition
SharesReturnedInConnectionWithAcquisition
940000 usd
CY2023 gryp Termination Of Contingent Consideration Obligation Due To Sale Of Discontinued Operations
TerminationOfContingentConsiderationObligationDueToSaleOfDiscontinuedOperations
2283806 usd
CY2022 gryp Reduction To Accrued Expenses From An Acquisitionrelated Working Capital Settlement
ReductionToAccruedExpensesFromAnAcquisitionrelatedWorkingCapitalSettlement
160000 usd
CY2023 us-gaap Nature Of Operations
NatureOfOperations
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 – Description of Business</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gryphon Digital Mining, Inc. (“Gryphon”), which originally began operations as Ivy Crypto, Inc., was incorporated under the provisions and by the virtue of the provisions of the General Corporation Law of the State of Delaware on October 22, 2020, with its office located in Las Vegas, Nevada. Gryphon operates a digital asset (commonly referred to as cryptocurrency) mining operation using specialized computers equipped with application-specific integrated circuit (ASIC) chips (known as “miners”) to solve complex cryptographic algorithms in support of the Bitcoin blockchain (in a process known as “solving a block”) in exchange for cryptocurrency rewards (primarily Bitcoin). Gryphon became a publicly held entity in February 2024 upon the completion of a reverse merger transaction (the “Merger”) with Akerna Corp., herein referred to as we, us, our, the Company or Akerna. These consolidated financial statements and notes thereto, including disclosures for certain activities up to and including the effective date (the “Effective Date”) of the Merger, or February 9, 2024, are exclusively attributable to the operations of Akerna. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Akerna was formed upon completion of the mergers between MTech Acquisition Corp. (“MTech”) and MJ Freeway, LLC (“MJF”) on June 17, 2019 as contemplated by the Merger Agreement dated October 10, 2018, as amended (the “Formation Mergers”). Akerna provided software as a service (“SaaS”) solutions within the cannabis industry that enabled regulatory compliance and inventory management through several wholly-owned subsidiaries including MJF, Trellis Solutions, Inc. (“Trellis”), Ample Organics, Inc. (“Ample”), Last Call Analytics (“LCA”), solo sciences, inc. (“Solo”), Viridian Sciences, Inc. (“Viridian”), and The NAV People, Inc. d.b.a. 365 Cannabis (“365 Cannabis”). Our common stock, $0.0001 par value (“Common Stock”) was traded on the Nasdaq Capital Market (the “Nasdaq”) under the symbol “KERN” through February 9, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the fourth quarter of 2022, we committed to a number of significant actions that collectively represented a strategic shift in our business strategy and a complete exit from the SaaS business serving the cannabis industry. The shift was effectuated in a two-part exit strategy whereby we (i) disposed of our component SaaS business units in advance of (ii) the Merger with Gryphon, an entity unaffiliated with the SaaS and cannabis industries (see below and Note 4).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Prior to the aforementioned shift in strategy, we implemented a restructuring initiative (the “Restructuring”) in May 2022 whereby we reduced our headcount by 59 employees and incurred and paid $0.6 million of associated costs in an effort to minimize costs and streamline the organization. There were no remaining obligations under the Restructuring after December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2023, we disposed of 365 Cannabis, LCA and Ample (the “Disposal Group”) through a series of sale transactions. As a result of these transactions, the Disposal Group met the criteria to be considered “discontinued operations” as that term is defined in accounting principles generally accepted in the United States (“GAAP”). Accordingly, the assets and liabilities of these entities are classified and reflected on our consolidated balance sheet as of December 31, 2022 as attributable to “discontinued operations” and their results of operations are classified as “discontinued operations” in the consolidated statements of operations for the years ended December 31, 2023 and 2022, respectively. Certain financial disclosures including major components of the assets and liabilities and results of operations of the Disposal Group are provided in Note 15. We effectively abandoned our operations for Trellis, Solo and Viridian during the year ended December 31, 2023 after all contractual commitments were satisfied with the customers and vendors of those businesses. The results of operations of these business units are reflected in these consolidated financial statements for all periods presented as a component of continuing operations. We committed to the sale of MJF (the “Sale Transaction”) during 2023; however, the required stockholder approval and certain other consents required to complete the Sale Transaction were not obtained until January of 2024. Accordingly, the assets and liabilities and results of operations of MJF are reflected in these consolidated financial statements for all periods presented as a component of continuing operations. The Sale Transaction closed on February 9, 2024 (see Note 4).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 27, 2023, we entered into an agreement and plan of merger, as amended on April 28, 2023 and June 14, 2023 (the “Merger Agreement”) with Gryphon and Akerna Merger Co. (“Akerna Merger”). Required approval of the Merger Agreement by the stockholders of Akerna and Gryphon as well as approval by Nasdaq of the continued listing of Gryphon after the closing of the Merger was obtained in January 2024. On February 9, 2024, concurrent with the closing of the Sale Transaction, Akerna Merger merged with and into Gryphon, with Gryphon surviving the Merger as a wholly-owned subsidiary of Akerna. Following the closing of the Merger, the former Gryphon and Akerna stockholders immediately before the Merger owned approximately 92.5 percent and 7.5 percent, respectively, of the outstanding capital stock on a fully diluted basis which effectively resulted in a change in control of the Company. Upon completion of the Merger, Akerna changed its name to Gryphon and its common stock began trading on the Nasdaq under the symbol “GRYP.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional disclosures regarding the Merger and Sale Transaction and their impact on the results of operations for the year ended December 31, 2023 are more fully described in Note 4.</span></p>
CY2022Q2 gryp Incurred Paid
IncurredPaid
600000 usd
CY2023 us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2 – Basis of Presentation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements, which exclusively represent the operations of Akerna through December 31, 2023 and disclosures regarding certain activities up to and including the Effective Date, have been prepared in accordance with GAAP. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Going Concern and Management</i>’<i>s Liquidity Plans</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standard Codification (“ASC”) 205-40, <i>Going Concern</i> (“ASC 205-40”), we assess going concern uncertainty in our consolidated financial statements to determine if we have sufficient cash, cash equivalents and working capital on hand and any available borrowings on loans, to operate for a period of at least one year from the date the consolidated financial statements are issued, which is defined as the “look-forward period” in ASC 205-40. As part of this assessment, based on conditions that are known and reasonably knowable to us, we will consider various scenarios, forecasts, projections, estimates and will make certain key assumptions, including the timing and nature of projected cash expenditures or programs, and our ability to delay or curtail expenditures or programs, if necessary, among other factors. Based on this assessment, as necessary or applicable, we make certain assumptions regarding implementing curtailments or delays in the nature and timing of programs and expenditures to the extent we deem probable that such implementations can be achieved and we have the proper authority to execute them within the look-forward period in accordance with ASC 205-40.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared on the basis that Akerna will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business. However, since our inception in 2019 we have incurred recurring losses from operations, used cash from operating activities and relied on capital raising activities to continue ongoing operations. Collectively, these factors raise substantial doubt regarding our ability to continue as a going concern for the twelve months from the date our consolidated financial statements were issued in the absence of a significant capital transaction. The accompanying consolidated financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should Akerna be unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">In connection with the closing of the Sale Transaction and Merger, substantially all of the assets and liabilities of the legacy Akerna business were disposed of such that after February 8, 2024, our assets and liabilities and capital structure reflected those of Gryphon immediately after the closing of those transactions. Since Gryphon began revenue generation in September 2021, management has financed its operations through equity and debt financing and the sale of the digital assets earned through mining operations. Gryphon may incur additional losses from operations and negative cash outflows from operations in the foreseeable future. In the event Gryphon continues to incur losses, it may need to raise debt or equity financing to finance its operations until operations are cashflow positive. However, there can be no assurance that such financing will be available in sufficient amounts and on acceptable terms, when and if needed, or at all. The precise amount and timing of the funding needs cannot be determined accurately at this time and will depend on several factors, including the market price for the underlying commodity mined by the Company and its ability to procure the required mining equipment and operate profitably. The aforementioned factors indicate that management’s plans do not alleviate the substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the issuance of these financial statements </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reclassifications</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior year amounts have been reclassified to conform to the current year presentation. In addition, and as described and disclosed in Notes 1 and 15, the assets and liabilities and results of operations of the Disposal Group have been reclassified as discontinued operations for all period presented.</span></p>
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of our consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts included in the consolidated financial statements and accompanying notes thereto. Our most significant estimates and assumptions are related to impairment assessments, loss contingencies and the valuation allowance associated with deferred tax assets. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Accordingly, actual results could differ from those estimates.  </span></p>
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
100000 usd
CY2023Q1 us-gaap Securities Purchased Under Agreements To Resell
SecuritiesPurchasedUnderAgreementsToResell
4000000 usd
CY2023Q2 us-gaap Investment Company Expense After Reduction Of Fee Waiver And Reimbursement
InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement
200000 usd
CY2023Q2 gryp Purchase Price Value
PurchasePriceValue
5000000 usd
CY2023Q2 gryp Purchase Price Value In Cash
PurchasePriceValueInCash
4000000 usd
CY2023 gryp Cash Paid
CashPaid
1850000 usd
CY2023Q4 us-gaap Cash
Cash
4000000 usd
CY2023Q4 us-gaap Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
1650000 usd
CY2023Q1 gryp Percent Of The Outstanding Shares Of Common Stock
PercentOfTheOutstandingSharesOfCommonStock
0.199 pure
CY2023Q1 us-gaap Common Stock Convertible Conversion Price Increase
CommonStockConvertibleConversionPriceIncrease
95
CY2023Q4 us-gaap Shares Issued
SharesIssued
1711 shares
CY2023Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
100 shares
CY2023 us-gaap Revenues
Revenues
6836444 usd
CY2022 us-gaap Revenues
Revenues
10458170 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
147855 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
429949 usd
CY2022Q4 gryp Percentage Of Account Receivable From Customers
PercentageOfAccountReceivableFromCustomers
0.51 pure
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
80759 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
331262 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
305517 usd
CY2023 gryp Accounts Receivable Allowancefor Credit Loss Bad Debt Expense
AccountsReceivableAllowanceforCreditLossBadDebtExpense
63358 usd
CY2022 gryp Accounts Receivable Allowancefor Credit Loss Bad Debt Expense
AccountsReceivableAllowanceforCreditLossBadDebtExpense
415009 usd
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
377148 usd
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
389264 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
17472 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
331262 usd
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2500000 usd
CY2023 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
6800000 usd
CY2022 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
10500000 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
500000 usd
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
1200000 usd
CY2023 gryp Customer Relationship Period
CustomerRelationshipPeriod
P1Y
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
154137 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
59070 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
105257 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21689 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48880 usd
CY2023 us-gaap Depreciation
Depreciation
27883 usd
CY2022 us-gaap Depreciation
Depreciation
44841 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
28700000 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
6100000 usd
CY2022Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
3900000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
18700000 usd
CY2022 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
2200000 usd
CY2022Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
4400000 usd
CY2022Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
700000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3700000 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
26500000 usd
CY2022 us-gaap Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
4600000 usd
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
3200000 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
18700000 usd
CY2023Q4 gryp Prepaid Expenses Software And Technology
PrepaidExpensesSoftwareAndTechnology
27518 usd
CY2022Q4 gryp Prepaid Expenses Software And Technology
PrepaidExpensesSoftwareAndTechnology
309466 usd
CY2023Q4 gryp Prepaid Professional Services Dues And Subscriptions
PrepaidProfessionalServicesDuesAndSubscriptions
4723 usd
CY2022Q4 gryp Prepaid Professional Services Dues And Subscriptions
PrepaidProfessionalServicesDuesAndSubscriptions
18268 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
168935 usd
CY2022Q4 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
36465 usd
CY2023Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
370326 usd
CY2022Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
534925 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
17515 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
53704 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
420082 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1121763 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2165342 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1417835 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1041699 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
143749 usd
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
107923 usd
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
63983 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
397754 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
334514 usd
CY2023Q4 gryp Accrued Contractors
AccruedContractors
160739 usd
CY2022Q4 gryp Accrued Contractors
AccruedContractors
521145 usd
CY2023Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
248031 usd
CY2022Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
934396 usd
CY2023Q4 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
699142 usd
CY2022Q4 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
597873 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9688 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4820630 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4023183 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
5149000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
14607000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5149000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
13200000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1407000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
4900000 usd
CY2023Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
3500000 usd
CY2022Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
14600000 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
650000 usd
CY2023Q4 gryp Aggregate Maturities
AggregateMaturities
3136271 usd
CY2023Q4 gryp Maturities Due For The Amended
MaturitiesDueForTheAmended
1650000 usd
CY2023Q4 gryp Debt Original Issue Discount
DebtOriginalIssueDiscount
2000000 usd
CY2023Q4 gryp Cumulative Unrealized Change In Fair Value
CumulativeUnrealizedChangeInFairValue
2362729 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5149000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-50000 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2826 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-47174 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-653945 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-653945 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-701119 usd
CY2023 gryp Tax Reconciliation Not Required
TaxReconciliationNotRequired
-2406564 usd
CY2022 gryp Tax Reconciliation Not Required
TaxReconciliationNotRequired
-16749778 usd
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-252836 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-853392 usd
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-76018 usd
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-11543 usd
CY2023 gryp Income Tax Reconciliation Transaction Costs
IncomeTaxReconciliationTransactionCosts
167137 usd
CY2023 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
207525 usd
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
472270 usd
CY2023 gryp Income Tax Reconciliation Goodwill Impairment
IncomeTaxReconciliationGoodwillImpairment
358744 usd
CY2022 gryp Income Tax Reconciliation Goodwill Impairment
IncomeTaxReconciliationGoodwillImpairment
9172756 usd
CY2023 gryp Income Tax Reconciliation Change In Rate
IncomeTaxReconciliationChangeInRate
-51003 usd
CY2022 gryp Income Tax Reconciliation Change In Rate
IncomeTaxReconciliationChangeInRate
-992 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-3591436 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
7501917 usd
CY2023 gryp Income Tax Reconciliation Provision Return Adjustment
IncomeTaxReconciliationProvisionReturnAdjustment
486727 usd
CY2022 gryp Income Tax Reconciliation Provision Return Adjustment
IncomeTaxReconciliationProvisionReturnAdjustment
62788 usd
CY2023 gryp Income Tax Reconciliation Deferred Trueups
IncomeTaxReconciliationDeferredTrueups
5157724 usd
CY2022 gryp Income Tax Reconciliation Deferred Trueups
IncomeTaxReconciliationDeferredTrueups
-247839 usd
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-47306 usd
CY2022 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-701119 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
63091 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
136154 usd
CY2022Q4 gryp Deferred Tax Assets Debt Issuance Costs
DeferredTaxAssetsDebtIssuanceCosts
39381 usd
CY2022Q4 gryp Deferred Tax Asset Revenue Recognition
DeferredTaxAssetRevenueRecognition
64662 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
49575 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
178549 usd
CY2023Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
171268 usd
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
774936 usd
CY2023Q4 gryp Deferred Tax Asset Section174 Capitalization
DeferredTaxAssetSection174Capitalization
1219926 usd
CY2022Q4 gryp Deferred Tax Asset Section174 Capitalization
DeferredTaxAssetSection174Capitalization
1121311 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
14226635 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
13860338 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
56739 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
4641293 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
4718 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
280430 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
15791952 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
21097054 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1713666 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1713666 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15791952 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19383388 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-3600000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
7500000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
59500000 usd
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.80 pure
CY2023Q4 us-gaap Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority
IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority
100000 usd
CY2023Q4 gryp Percentage Of Commitment To Compensate Financial Advisor
PercentageOfCommitmentToCompensateFinancialAdvisor
0.03 pure
CY2023Q4 gryp Accrued Advisor
AccruedAdvisor
650000 usd
CY2023Q2 gryp Termination Fee And Related Expenses
TerminationFeeAndRelatedExpenses
200000 usd
CY2022Q4 gryp Original Issue Discount To The Stated Value Percentage
OriginalIssueDiscountToTheStatedValuePercentage
0.05 pure
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10
CY2022Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4750000 usd
CY2022Q4 us-gaap Professional Fees
ProfessionalFees
400000 usd
CY2022Q4 us-gaap Legal Fees
LegalFees
100000 usd
CY2022Q4 us-gaap Escrow Deposit
EscrowDeposit
500000 usd
CY2022Q4 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
5
gryp Convertible Redeemable Preferred Stock Percent
ConvertibleRedeemablePreferredStockPercent
1.05 pure
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.5
CY2022Q4 us-gaap Escrow Deposit
EscrowDeposit
5250000 usd
CY2023Q4 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
3422 shares
CY2023Q4 us-gaap Convertible Debt
ConvertibleDebt
3422000 usd
CY2023Q4 gryp Exchangeable Shares Outstanding
ExchangeableSharesOutstanding
248484 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
92
CY2022Q3 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
9200000 usd
CY2022Q3 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
7000000 usd
CY2023Q4 gryp Warrants Outstanding
WarrantsOutstanding
45652174 shares
CY2023 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
114130 shares
CY2023Q4 gryp Common Warrants Shares
CommonWarrantsShares
43478261 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9200000 usd
CY2023 us-gaap Class Of Warrant Or Right Expense Or Revenue Recognized
ClassOfWarrantOrRightExpenseOrRevenueRecognized
In connection with MTech’s initial public offering, MTech sold units consisting of one share of MTech’s common stock and one warrant of MTech (“MTech Public Warrant”). Each MTech Public Warrant entitled the holder to purchase one share of MTech’s common stock. Concurrently with MTech’s initial public offering, MTech sold additional units on a private offering basis. Each of these units consisted of one share of MTech’s common stock and one warrant of MTech (“MTech Private Warrant”).
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
51465978 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
51465978 shares
CY2019Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1040038 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
525000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
2934962 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
11250 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
8714 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1790 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2188
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
707 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
270.8
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1188 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1081.2
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
739 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
2248.2
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
570 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1793.2
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
276 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
2045.8
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
113 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
1372.4
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
181 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1801
CY2022 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
100000 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
300000 usd
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y10M13D
CY2023Q4 us-gaap Fair Value Liabilities Measured On Recurring Basis Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisObligations
6300000 usd
CY2022Q3 us-gaap Fair Value Liabilities Measured On Recurring Basis Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisObligations
3000000 usd
CY2022Q4 us-gaap Fair Value Liabilities Measured On Recurring Basis Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisObligations
2300000 usd
CY2021Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
17305000 usd
CY2022 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
5337273 usd
CY2022 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
2884273 usd
CY2022 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-245000 usd
CY2022Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
14607000 usd
CY2023 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
11526457 usd
CY2023 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
370457 usd
CY2023 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
48000 usd
CY2023Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
3499000 usd
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
162483 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
284296 shares
CY2023Q1 gryp Termination Of Contingent Consideration Obligation Due To Sale Of Discontinued Operations
TerminationOfContingentConsiderationObligationDueToSaleOfDiscontinuedOperations
500000 usd
CY2022Q4 us-gaap Purchase Obligation
PurchaseObligation
2300000 usd
CY2022Q4 gryp Orginal Estimate Amount
OrginalEstimateAmount
4000000 usd
CY2023Q1 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
100000 usd
CY2023 us-gaap Other Adjustments To Income Discontinued Operations
OtherAdjustmentsToIncomeDiscontinuedOperations
200000 usd
CY2023 us-gaap Proceeds From Sale And Collection Of Receivables
ProceedsFromSaleAndCollectionOfReceivables
638000 usd
CY2023 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
2412534 usd
CY2022 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
12640170 usd
CY2023 us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
575246 usd
CY2022 us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
2919208 usd
CY2023 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
1837288 usd
CY2022 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
9720962 usd
CY2023 gryp Discontinued Operation Product And Development Expense
DiscontinuedOperationProductAndDevelopmentExpense
527301 usd
CY2022 gryp Discontinued Operation Product And Development Expense
DiscontinuedOperationProductAndDevelopmentExpense
2409740 usd
CY2023 gryp Discontinued Operation Selling And Marketing Expense
DiscontinuedOperationSellingAndMarketingExpense
421049 usd
CY2022 gryp Discontinued Operation Selling And Marketing Expense
DiscontinuedOperationSellingAndMarketingExpense
4646997 usd
CY2023 gryp Disposal Group Including Discontinued Operation General And Administrative
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrative
118133 usd
CY2022 gryp Disposal Group Including Discontinued Operation General And Administrative
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrative
798837 usd
CY2023 us-gaap Disposal Group Including Discontinued Operation Depreciation And Amortization
DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization
891708 usd
CY2022 us-gaap Disposal Group Including Discontinued Operation Depreciation And Amortization
DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization
3412717 usd
CY2023 gryp Discontinued Operation Impairment Of Long Lived Assets Held For Use
DiscontinuedOperationImpairmentOfLongLivedAssetsHeldForUse
3065365 usd
CY2022 gryp Discontinued Operation Impairment Of Long Lived Assets Held For Use
DiscontinuedOperationImpairmentOfLongLivedAssetsHeldForUse
35249975 usd
CY2022 gryp Disposalof Group Changes In Fair Value Of Contingent Consideration
DisposalofGroupChangesInFairValueOfContingentConsideration
-4016194 usd
CY2023 us-gaap Disposal Group Including Discontinued Operation Other Expense
DisposalGroupIncludingDiscontinuedOperationOtherExpense
1833 usd
CY2022 us-gaap Disposal Group Including Discontinued Operation Interest Expense
DisposalGroupIncludingDiscontinuedOperationInterestExpense
746 usd
CY2023 gryp Loss From Discontinued Operations Before Income Taxes
LossFromDiscontinuedOperationsBeforeIncomeTaxes
-3188101 usd
CY2022 gryp Loss From Discontinued Operations Before Income Taxes
LossFromDiscontinuedOperationsBeforeIncomeTaxes
-32781856 usd
CY2022 us-gaap Discontinued Operation Tax Expense Benefit From Provision For Gain Loss On Disposal
DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal
2117 usd
CY2023 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-3188101 usd
CY2022 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-32779739 usd
CY2023 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
212601 usd
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-2975500 usd
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-32779739 usd
CY2023 gryp Disposal Group Including Discontinued Operation In Impairments Of Longlived Assets
DisposalGroupIncludingDiscontinuedOperationInImpairmentsOfLonglivedAssets
3100000 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Goodwill Current
DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent
1700000 usd
CY2022 gryp Disposal Group Including Discontinued Operation In Impairments Of Longlived Assets
DisposalGroupIncludingDiscontinuedOperationInImpairmentsOfLonglivedAssets
35200000 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Goodwill Current
DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent
25000000 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Intangible Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent
9900000 usd
CY2022 gryp Disposal Group Including Discontinued Operation In Capitalized Software
DisposalGroupIncludingDiscontinuedOperationInCapitalizedSoftware
300000 usd
CY2022 gryp Disposal Group Including Discontinued Operation Accounts Receivable Credit Loss Expense Reversal
DisposalGroupIncludingDiscontinuedOperationAccountsReceivableCreditLossExpenseReversal
1700000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
200000 usd
CY2023 dei Auditor Firm
AuditorFirmId
688
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
usd
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
usd
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
usd
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
usd
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
usd
CY2022 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-322.65
CY2023 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-23.19
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-223.92
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-8.02
CY2022 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2022 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
usd
CY2023 gryp Stock Issued During Period Value Restricted Stock Vesting
StockIssuedDuringPeriodValueRestrictedStockVesting
usd
CY2022 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
usd
CY2023 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
usd
CY2023 us-gaap Other Noncash Expense
OtherNoncashExpense
usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
CY2023 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
usd
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
usd
CY2023 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
usd
CY2023 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
usd
CY2023 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
usd
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
usd
CY2022 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
usd
CY2023 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
usd
CY2023 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
CY2023 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
usd
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
CY2023 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
usd
CY2022 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
usd
CY2023 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
usd
CY2023 us-gaap Payments For Repurchase Of Redeemable Convertible Preferred Stock
PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock
usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023 gryp Vesting Of Restricted Stock Units
VestingOfRestrictedStockUnits
usd
CY2022 gryp Settlement Of Convertible Notes In Preferred Stock
SettlementOfConvertibleNotesInPreferredStock
usd
CY2023 gryp Stock Based Compensation Capitalized As Software Development
StockBasedCompensationCapitalizedAsSoftwareDevelopment
usd
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
usd
CY2023 gryp Settlement Of Liabilities With Common Stock
SettlementOfLiabilitiesWithCommonStock
usd
CY2023 gryp Shares Returned In Connection With Acquisition
SharesReturnedInConnectionWithAcquisition
usd
CY2022 gryp Termination Of Contingent Consideration Obligation Due To Sale Of Discontinued Operations
TerminationOfContingentConsiderationObligationDueToSaleOfDiscontinuedOperations
usd
CY2023 gryp Reduction To Accrued Expenses From An Acquisitionrelated Working Capital Settlement
ReductionToAccruedExpensesFromAnAcquisitionrelatedWorkingCapitalSettlement
usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
usd
CY2023Q4 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 gryp Income Tax Reconciliation Transaction Costs
IncomeTaxReconciliationTransactionCosts
usd
CY2023 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
usd
CY2023 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
usd
CY2023Q4 gryp Deferred Tax Assets Debt Issuance Costs
DeferredTaxAssetsDebtIssuanceCosts
usd
CY2023Q4 gryp Deferred Tax Asset Revenue Recognition
DeferredTaxAssetRevenueRecognition
usd
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2023 gryp Warrants Issued In Periods Number Of Shares
WarrantsIssuedInPeriodsNumberOfShares
shares
CY2023 gryp Warrants Forfeited In Period Weighted Average Grant Date Fair Value
WarrantsForfeitedInPeriodWeightedAverageGrantDateFairValue
CY2023 gryp Class Of Warrant Or Righst From Which Warrants Or Rights Expired
ClassOfWarrantOrRighstFromWhichWarrantsOrRightsExpired
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023 gryp Disposalof Group Changes In Fair Value Of Contingent Consideration
DisposalofGroupChangesInFairValueOfContingentConsideration
usd
CY2022 us-gaap Disposal Group Including Discontinued Operation Other Expense
DisposalGroupIncludingDiscontinuedOperationOtherExpense
usd
CY2023 us-gaap Disposal Group Including Discontinued Operation Interest Expense
DisposalGroupIncludingDiscontinuedOperationInterestExpense
usd
CY2023 us-gaap Discontinued Operation Tax Expense Benefit From Provision For Gain Loss On Disposal
DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal
usd
CY2022 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
usd
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001755953

Files In Submission

Name View Source Status
0001213900-24-028732-index-headers.html Edgar Link pending
0001213900-24-028732-index.html Edgar Link pending
0001213900-24-028732.txt Edgar Link pending
0001213900-24-028732-xbrl.zip Edgar Link pending
ea0202248-10k_gryphon.htm Edgar Link pending
ea020224801ex10-22_gryphon.htm Edgar Link pending
ea020224801ex10-23_gryphon.htm Edgar Link pending
ea020224801ex10-24_gryphon.htm Edgar Link pending
ea020224801ex19-1_gryphon.htm Edgar Link pending
ea020224801ex21-1_gryphon.htm Edgar Link pending
ea020224801ex23-1_gryphon.htm Edgar Link pending
ea020224801ex3-4_gryphon.htm Edgar Link pending
ea020224801ex31-1_gryphon.htm Edgar Link pending
ea0202248-10k_gryphon_htm.xml Edgar Link completed
ea020224801ex31-2_gryphon.htm Edgar Link pending
ea020224801ex32-1_gryphon.htm Edgar Link pending
ea020224801ex32-2_gryphon.htm Edgar Link pending
ea020224801ex4-1_gryphon.htm Edgar Link pending
ea020224801ex97-1_gryphon.htm Edgar Link pending
ex10-23_001.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gryp-20231231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
gryp-20231231_cal.xml Edgar Link unprocessable
gryp-20231231_def.xml Edgar Link unprocessable
gryp-20231231_lab.xml Edgar Link unprocessable
gryp-20231231_pre.xml Edgar Link unprocessable
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable